<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1401510</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2024.1401510</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Nucleosides, nucleotides and nucleic acids: chemistry and biology</article-title>
<alt-title alt-title-type="left-running-head">Soter de Mariz e Miranda et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2024.1401510">10.3389/fchem.2024.1401510</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Soter de Mariz e Miranda</surname>
<given-names>Leandro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1145241/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schroeder Borges Gon&#xe7;alves</surname>
<given-names>Raoni</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uziel</surname>
<given-names>Jacques</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1967351/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Obika</surname>
<given-names>Satoshi</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1965655/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lubin-Germain</surname>
<given-names>Nadege</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1430678/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Biocatalysis and Organic Synthesis Group</institution>, <institution>Universidade Federal do Rio de Janeiro</institution>, <institution>Centro de Tecnologia</institution>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>CY Cergy-Paris Universit&#xe9;</institution>, <institution>BioCIS</institution>, <institution>CNRS</institution>, <addr-line>Cergy</addr-line>, <country>France</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Universit&#xe9; Paris-Saclay</institution>, <institution>CNRS</institution>, <institution>BioCIS</institution>, <addr-line>Ch&#xe2;tenay-Malabry</addr-line>, <country>France</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Graduate School of Pharmaceutical Sciences</institution>, <institution>Osaka University</institution>, <addr-line>Suita</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/22879/overview">John D. Wade</ext-link>, University of Melbourne, Australia</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Nadege Lubin-Germain, <email>nadege.lubin-germain@cyu.fr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1401510</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Soter de Mariz e Miranda, Schroeder Borges Gon&#xe7;alves, Uziel, Obika and Lubin-Germain.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Soter de Mariz e Miranda, Schroeder Borges Gon&#xe7;alves, Uziel, Obika and Lubin-Germain</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Chem." xlink:href="https://www.frontiersin.org/researchtopic/42100" ext-link-type="uri">Editorial on the Research Topic <article-title>Nucleosides, nucleotides and nucleic acids: chemistry and biology</article-title>
</related-article>
<kwd-group>
<kwd>nucleosides</kwd>
<kwd>nucleotides</kwd>
<kwd>nucleic acids</kwd>
<kwd>metal-dependant DNA methylation level</kwd>
<kwd>therapeutic agents</kwd>
<kwd>enzymatic synthesis</kwd>
<kwd>vorbruggen conditions</kwd>
<kwd>phosphate mimics</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Chemical Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Nucleosides and nucleotides constitute the elementary building blocks of nucleic acids, fundamental molecular components of life playing an essential role in heredity by transmitting and storing genetic information (<xref ref-type="bibr" rid="B4">Minchin and Lodge, 2019</xref>). Here we bring together the contributions on this Research Topic and will address the problem of synthesis, epigenetics and the therapeutic approach (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1122474">Liu et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1161462">Sabat et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2022.1051525">Berdis</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1163486">Naciuk et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2024.1342178">Sergeeva et al.</ext-link>).</p>
<p>DNA expression depends on nucleotides post replication chemical modifications. One of them is the DNA methylation occurring exclusively at C-5 in the pyrimidine ring of cytosine as an epigenetic marker in CpG dinucleotides promoters. The methylation level is directly connected to the promotion or dysfunction of biological processes such as carcinogenesis. The question of factors disrupting the methylation equilibrium is of a great interest and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1122474">Liu et al.</ext-link> explored the role of metals on the DNA methylation level. The authors confirmed the effects of metal ions on DNA methylation in a sequence-specific manner using fluorescent <italic>in situ</italic> hybridization (FISH) methodology.</p>
<p>Nucleic acids are also involved in numerous cellular processes such as cell signaling (ATP as an energy source and cAMP as a second messenger transmitting information inside the cell), protein translation by transfer RNAs which delivers the correct amino acid or duplication processes (DNA replication or transcription into messenger RNA) using the constituent building blocks.</p>
<p>The synthesis of nucleic acids by molecular biology techniques such as Polymerase Chain Reaction (PCR) enables access to macromolecular diversity with good fidelity and sufficient quantity. The best example is the discovery and production of <italic>m</italic>-RNA vaccines such as the one against COVID-19. Several vaccines are already in clinical trials for infectious diseases (influenza, Zika virus, Nipah virus, respiratory syncytial virus), and for genetic disorders and cancers (Khan et al., 2023). Moreover, DNA being a system coded by 4 nucleobases, it has been considered in recent years as a valuable medium for storing information to meet the energy costs of current servers. DNA has a sufficiently stable chemical structure since it has been possible to sequence the mammoth genetic code, and it can be produced in the form of a very long chain by PCR (<xref ref-type="bibr" rid="B1">Doricchi et al., 2022</xref>).</p>
<p>In addition to molecular biology techniques, nucleic acids can be obtained by synthesis using the couplings of phosphoramidite nucleotide derivatives. This technique employs chemical reactions to sequentially add nucleotides to a solid matrix, following the specified desired sequence for antisense oligonucleotide ASO (<xref ref-type="bibr" rid="B2">Duffy et al., 2020</xref>). Even if both conditions are efficient, sustainability and scalability require new improvements as suggested by Hollenstein <italic>et al.</italic> who considered an enzymatic approach using a template-independent polymerase such as the terminal deoxynucleotidyl transferase (TdT) or Poly(U) polymerases (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1161462">Sabat et al.</ext-link>) with C3&#x2032;-protected (locked) nucleotides. In addition, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2024.1342178">Sergeeva et al.</ext-link> were interested in alternative phosphate mimics for RNA therapeutics. They proposed to advantageously replace phosphothiolate bonds, most often proposed for ASO gapmers, with <italic>N</italic>-alkane sulfonyl phosphoramidate groups such as mesyl (methanesulfonyl) or busyl (1-butanesulfonyl) phosphoramidates to improve biological properties, RNase H cleavage, cellular uptake <italic>in vitro</italic>, and intracellular localization.</p>
<p>Concerning nucleosides and nucleotides, they have been of particular interest for several decades following the HIV virus discovery. The therapeutic success of the nucleoside Zidovudine (azidothymidine) A therapeutic approach has led to the synthesis of numerous families of active and specific antiviral nucleosides. In addition, the development of broad-spectrum nucleosides opens up possibilities for combined therapy. Recently, the prodrug approach leading to the <italic>in cellulo</italic> delivery of nucleotides has led to significant advancements, as demonstrated in the treatment of hepatitis C with sofosbuvir. As another example, A. Berdis (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2022.1051525">Berdis</ext-link>) reports pre-clinical studies using nucleobase-modified nucleosides as potential therapeutic agents against diseases such as cancer. More generally the introduction of non-natural nucleotides is extensively studied to examine the contributions of shape/size, nucleobase hydrophobicity, and pi-electron interactions, to improve the strand complementarity in an antisense approach, or introduce modified nucleotide for synthetic biological uses.</p>
<p>Access to nucleosides and nucleotides analogues remains a challenge, as their therapeutic interest is so important. This requires efficient and stereochemically controlled synthetic methodologies. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1163486">Naciuk et al.</ext-link> revisit the Vorbruggen coupling reaction for weakly reactive nucleobases, in the presence of Lewis acids. The authors then describe the synthesis of 7-deaza-2&#x2032;-methyladenosine (7DMA) employing Vorbr&#xfc;ggen conditions, as well as preliminary results of efficacy against an emerging flavivirus <italic>in vitro</italic>.</p>
<p>As evident, the chemistry and biology of these compounds, from the elementary building blocks to biopolymers, are rich both synthetically and in their biomedical applications. If complexity is demonstrated by sequence (DNA <italic>versus</italic> RNA), supramolecular aspects (messenger, transfer, cyclic <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mo>&#x2026;</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula>) their conformational properties (single/double strand, quadruplexes <inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:mo>&#x2026;</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula>) have to be considered as well. For all these reasons, progress associated with this field has been significant in recent years, and it seems important to take a specific interest.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>LS: Writing&#x2013;review and editing. RS: Writing&#x2013;review and editing. JU: Writing&#x2013;review and editing. SO: Writing&#x2013;review and editing. NL&#x2013;G: Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s2">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doricchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Platnich</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Gimpel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Earle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lanzavecchia</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Emerging approaches to DNA data storage: challenges and prospects</article-title>. <source>ACS Nano</source> <volume>16</volume> (<issue>11</issue>), <fpage>17552</fpage>&#x2013;<lpage>17571</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.2c06748</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arangundy-Franklin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hollige</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Modified nucleic acids: replication, evolution, and next-generation therapeutics</article-title>. <source>BMC Biol.</source> <volume>18</volume>, <fpage>112</fpage>. <pub-id pub-id-type="doi">10.1186/s12915-020-00803-6</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gote</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bolla</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Kommineni</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Butreddy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nukala</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Palakurthi</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Comprehensive review of mRNA vaccines: comprehensive review of mRNA vaccines</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>, <fpage>2700</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24032700</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minchin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lodge</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Understanding biochemistry: structure and function of nucleic acids</article-title>. <source>Essays Biochem.</source> <volume>63</volume>, <fpage>433</fpage>&#x2013;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1042/EBC20180038</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>